August 18, 2025

Edwards Lifesciences Corporatio (EW)

⚠️ No article content returned.

..

Merck & Company, Inc. (MRK) Stock Analysis: Evaluating a 19.24% Upside Potential Amid Healthcare Innovations

Merck & Company, Inc. (NYSE: MRK), a titan in the healthcare industry, presents a compelling opportunity for investors as it navigates the complexities of the pharmaceutical and animal health sectors...

Humana Inc. (HUM) Stock Analysis: Navigating Growth in Healthcare Plans

Humana Inc. (NYSE: HUM) stands as a formidable player in the healthcare plans industry, a sector that continues to experience robust demand and growth prospects. With a market capitalization of..

Centene Corporation (CNC) Investor Outlook: Exploring a 21% Potential Upside Amid Healthcare Growth

Centene Corporation (NYSE: CNC), a leading player in the healthcare plans industry, presents an intriguing opportunity for investors seeking exposure in the healthcare sector. With a market capitalization of $13.99..

Intuitive Surgical (ISRG) Stock Analysis: Exploring a 21.53% Potential Upside in the Healthcare Sector

Intuitive Surgical, Inc. (NASDAQ: ISRG), a leader in the healthcare sector, stands at the forefront of revolutionizing minimally invasive surgical procedures. With a market capitalization of $172.16 billion, the company..

Elevance Health, Inc. (ELV) Stock Analysis: Exploring a 19% Potential Upside Driven by Robust Revenue Growth

For investors seeking opportunities within the healthcare sector, Elevance Health, Inc. (NYSE: ELV) presents a compelling case with a formidable market presence and promising financial indicators. With its roots deeply..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Exploring a 19.9% Potential Upside in Healthcare Innovation

GE HealthCare Technologies Inc. (NYSE: GEHC), a key player in the healthcare sector, is drawing attention from investors with a notable potential upside of 19.9%. As a leading force in..

argenx SE (ARGX) Stock Analysis: A 23% Potential Upside in the Biotech Sector

argenx SE (NASDAQ: ARGX), a Netherlands-based biotech powerhouse, continues to command attention in the healthcare sector with its robust pipeline of therapies targeting a range of autoimmune diseases. With a..

Pfizer, Inc. (PFE) Stock Analysis: A 14.81% Potential Upside and Robust Dividend Yield

Pfizer, Inc. (NYSE: PFE), a stalwart in the healthcare sector, continues to capture investor attention with its robust dividend yield and promising potential upside. With a market capitalization of approximately..

Bristol-Myers Squibb (BMY) Stock Analysis: Navigating Healthcare’s Complex Landscape with a 9.41% Upside Potential

Bristol-Myers Squibb Company (NYSE: BMY), a stalwart in the healthcare sector, continues to hold a significant position in the global biopharmaceutical landscape. With a market capitalization of $98.6 billion, BMY..

Abbott Laboratories (ABT): Investor Outlook Reveals 8.15% Potential Upside

Abbott Laboratories (NYSE: ABT) stands out in the healthcare sector, particularly within the medical devices industry, with a market capitalization of $229.31 billion. Abbott’s diverse operations across pharmaceuticals, diagnostics, nutrition,..

HCA Healthcare, Inc. (HCA) Stock Analysis: Exploring the Financial Health and Investment Potential

HCA Healthcare, Inc. (NYSE: HCA) stands as a formidable entity in the U.S. healthcare sector, commanding a market capitalization of approximately $92.61 billion. As a prominent player in the medical..

Gilead Sciences, Inc. (GILD) Investor Outlook: Navigating a 3.39% Upside in the Healthcare Sector

Gilead Sciences, Inc. (GILD), a titan in the healthcare sector with a market capitalization of $146.87 billion, stands as a beacon of innovation in the biopharmaceutical industry. Headquartered in Foster..

AbbVie Inc. (ABBV) Stock Analysis: Solid Returns and a Promising 3.91% Upside Potential

AbbVie Inc. (NYSE: ABBV), a titan in the healthcare sector, continues to attract investor attention with its robust portfolio of pharmaceutical products and a promising upside potential of 3.91% according..

Melrose Industries Plc appoints Guy Hachey as Non-Executive Director

Melrose Industries has appointed aerospace industry veteran Guy Hachey to its Board as Non-executive Director. Hachey brings over 30 years of leadership experience from Bombardier Aerospace, Delphi, and Advent International,..

Landsec sells Queen Anne’s Mansions office block for £245m

Landsec has agreed the £245m unconditional sale of its Queen Anne’s Mansions office block in SW1 to Arora Group. The deal, which crystallises redevelopment value and delivers an immediate uplift..

HICL Infrastructure Plc agrees £225m sale of seven UK PPP assets

HICL has agreed to sell a portfolio of seven UK PPP assets to APG for around £225m, in line with its March 2025 valuation. Proceeds will support the £150m share..

Cizzle Biotechnology to launch CIZ1B cancer test across USA

Cizzle Biotechnology has announced that its North American partner, Cizzle Bio Inc, has signed an agreement with a multi-site accredited laboratory group to roll out the CIZ1B biomarker test for..

Great Portland Estates secures £2.5m fully managed leasing deals in London

GPE has completed three new Fully Managed leasing agreements totalling 11,720 sq ft across SIX St Andrew Street, EC4 and 31/34 Alfred Place, WC1. The deals, let to global business..

Aptamer secures contract Eetension with top 5 pharma partner

Aptamer has extended its collaboration with a top 5 global pharmaceutical company to advance Optimer® binders into a fully functional ELISA assay. The agreement builds on the successful completion of..
Search

Funds

August 18, 2025

Melrose Industries Plc appoints Guy Hachey as Non-Executive Director

Melrose Industries has appointed aerospace industry veteran Guy Hachey to its Board as Non-executive Director. Hachey brings over 30 years of leadership experience from Bombardier Aerospace, Delphi, and Advent International, and currently serves as a director at Hexcel Corporation...

Landsec sells Queen Anne’s Mansions office block for £245m

Landsec has agreed the £245m unconditional sale of its Queen Anne’s Mansions office block in SW1 to Arora Group. The deal, which crystallises redevelopment value and delivers an immediate uplift to return on equity, marks early progress towards Landsec’s plan to release £2bn from offices by 2030...

HICL Infrastructure Plc agrees £225m sale of seven UK PPP assets

HICL has agreed to sell a portfolio of seven UK PPP assets to APG for around £225m, in line with its March 2025 valuation. Proceeds will support the £150m share buyback programme and meet outstanding equity commitments, bringing total disposals over the past two years to about £725m at strong valuations...

Cizzle Biotechnology to launch CIZ1B cancer test across USA

Cizzle Biotechnology has announced that its North American partner, Cizzle Bio Inc, has signed an agreement with a multi-site accredited laboratory group to roll out the CIZ1B biomarker test for early lung cancer detection across the USA...

Great Portland Estates secures £2.5m fully managed leasing deals in London

GPE has completed three new Fully Managed leasing agreements totalling 11,720 sq ft across SIX St Andrew Street, EC4 and 31/34 Alfred Place, WC1. The deals, let to global business and technology firms including EKU Energy, will generate £2.5 million in annual rent, 2.8% ahead of the March 2025 ERV...

Aptamer secures contract Eetension with top 5 pharma partner

Aptamer has extended its collaboration with a top 5 global pharmaceutical company to advance Optimer® binders into a fully functional ELISA assay. The agreement builds on the successful completion of the initial binder development phase, with Aptamer retaining IP ownership to support future commercialisation opportunities...
Search

Funds

August 18, 2025

FTSE 100

Funds